Duloxetine-Induced Sleep Bruxism and Tooth Fracture in Fibromyalgia

Duloxetine is a serotonin-norepinephrine reuptake inhibitor that is approved for the treatment of fibromyalgia. Duloxetine has many side effects such as nausea, somnolence, insomnia, decreased appetite, dry mouth, and constipation. Sleep bruxism is also a very rare side effect of duloxetine. In this case report, a case of a 35-year-old male patient who developed sleep bruxism in the 4th week after duloxetine use, and fracture of the 1st upper molar tooth which had previously undergone root canal treatment after severe bruxism in the 6th week was presented. Duloxetine treatment was stopped and treatment was continued with amitriptyline. The patient had a significant reduction in both bruxism and fibromyalgia symptoms after the amitriptyline treatment. Bruxism symptoms were not observed after one year of follow-up.

Authors

Institutions

Publication Details

Journal
Düzce Tıp Fakültesi Dergisi
Published
2024-11-08
DOI
https://doi.org/10.18678/dtfd.1448234
Primary Topic
Temporomandibular Joint Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Duloxetine-Induced Sleep Bruxism and Tooth Fracture in Fibromyalgia

Murat Toprak, İsmail Tunçekin
1 links
Düzce Tıp Fakültesi Dergisi
Temporomandibular Joint Disorders
article

Duloxetine-Induced Sleep Bruxism and Tooth Fracture in Fibromyalgia

Murat Toprak, İsmail Tunçekin
article en

Abstract

Duloxetine is a serotonin-norepinephrine reuptake inhibitor that is approved for the treatment of fibromyalgia. Duloxetine has many side effects such as nausea, somnolence, insomnia, decreased appetite, dry mouth, and constipation. Sleep bruxism is also a very rare side effect of duloxetine. In this case report, a case of a 35-year-old male patient who developed sleep bruxism in the 4th week after duloxetine use, and fracture of the 1st upper molar tooth which had previously undergone root canal treatment after severe bruxism in the 6th week was presented. Duloxetine treatment was stopped and treatment was continued with amitriptyline. The patient had a significant reduction in both bruxism and fibromyalgia symptoms after the amitriptyline treatment. Bruxism symptoms were not observed after one year of follow-up.

Düzce Tıp Fakültesi DergisiVol. 26(3)
Van Yüzüncü Yıl Üniversitesi (TR), İstanbul Eğitim ve Araştırma Hastanesi (TR)
Good health and well-being
Openalex Percentile: Top 73%
Temporomandibular Joint Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.